NDC 16729-211

Doxazosin 1 mg tablet

On the label: Accord Healthcare Inc..

Where it's made

Recalls

• Feb 7, 2023 · Class II · Accord Healthcare, Inc.
  CGMP Deviations: recalling drug products following an FDA inspection.
  Lots: Batches: a) R2200402, Exp. Date 5/31/2024; R2200642, Exp. Date 5/31/2024; R2200643 Exp. Date 8/31/2024; R2201300 Exp. Date 8/31/2024; b) R2200403, Exp. Date 5/31/2024;
• Feb 7, 2023 · Class II · Accord Healthcare, Inc.
  CGMP Deviations: recalling drug products following an FDA inspection.
  Lots: Batches: a) R2200401, Exp. Date 5/31/2024; R2200675, Exp. Date 5/31/2024; R2200676 Exp. Date 11/30/2024; R2201070, Exp. Date 7/31/2025; b) R2200680, Exp. Date 9/30/2024;
• Feb 7, 2023 · Class II · Accord Healthcare, Inc.
  CGMP Deviations: recalling drug products following an FDA inspection.
  Lots: Batches: a) R2200352, Exp. Date 5/31/2024; R2200356, Exp. Date 8/31/2024; R2200357, Exp. Date 8/31/2024; R2200633, Exp. Date 4/30/2025; R2200634, Exp. Date 4/30/2025; b) R2200677,Exp. Date 8/31/2024; R2200572,Exp. Date 4/30/2025; R2200571, Exp. Date 4/30/2025; R2200646, Exp. Date 4/30/2025;
• Feb 7, 2023 · Class II · Accord Healthcare, Inc.
  CGMP Deviations: recalling drug products following an FDA inspection.
  Lots: Batches: a) R2200672, Exp. Date 5/31/2024; R2200673, Exp. Date 9/30/2024; R2201097, Exp. Date 7/31/2025; b) R2200678, Exp. Date 10/31/2024;

Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.

Product details

Generic drug

Doxazosin: every company that makes it

Form

tablet, oral

Strength

1 mg

Approval

ANDA ANDA202824

On the market since

Mar 4, 2015

Package NDCs

16729-211-01 16729-211-17

Official label

DailyMed (National Library of Medicine), updated Aug 15, 2024

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?